Increase/Decrease in Cash: The total change in cash for the company over the given period.
Astria Therapeutics, Inc. (ATXS) had Increase/Decrease in Cash of $155.00M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-72.89M |
|
-- |
|
-- |
|
$83.03M |
|
$-83.03M |
|
$10.14M |
|
$-72.89M |
|
$-72.89M |
|
$-72.89M |
|
$-72.89M |
|
$-72.89M |
|
$-72.89M |
|
$-83.03M |
|
$-83.03M |
|
30.12M |
|
30.12M |
|
$-2.42 |
|
$-2.42 |
|
| Balance Sheet Financials | |
$250.94M |
|
-- |
|
$3.72M |
|
$254.67M |
|
$11.55M |
|
-- |
|
$95.32M |
|
$106.87M |
|
$147.79M |
|
$147.79M |
|
$147.79M |
|
41.03M |
|
| Cash Flow Statement Financials | |
$-68.44M |
|
$135.05M |
|
$88.40M |
|
$20.69M |
|
$175.69M |
|
|
Increase/Decrease in Cash |
$155.00M |
$6.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-68.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-49.32% |
|
-49.32% |
|
-28.62% |
|
-49.32% |
|
$3.60 |
|
$-2.27 |
|
$-2.27 |
|